About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Current Search
Report Type
Organization
Disposition
Year
Month
Found 1395 record(s)
Req # A-2019-000343
Documentation on an operating instrument, from the request for approval until its recall. Licence number: 81556, Licence name: "Exair anterior prolapse repair system." This product was recalled on May 8, 2019. Identifier: 501000 and 50100, and also find out the reason for the recall.Organization: Health Canada
November 2021
Req # A-2020-000369
All correspondence between Health Canada and Biotrade Canada Ltd. concerning the recall of the products sold in Canada (Natural Product Number (NPNs) 80070773, 80072688, 80088075, 80070691, 80072690, and 80088078).Organization: Health Canada
November 2021
Req # A-2020-000705
Electronic versions of the reviewer reports for the approval of Zoloft.Organization: Health Canada
November 2021
Req # A-2020-000796
Documents related to novel food safety assessment for Martek DHA-O Algal Oil. The decision date for this novel food was 2011/08/10 according to Health Canada (HC’s) website. Copy of the full dossier submitted by the applicant, copy of the review performed by Health Canada and a copy of any correspondance between the applicant and Health Canada regarding this application.Organization: Health Canada
November 2021
Req # A-2020-000943
Information regarding the following product: Drug identification number (DIN): UNISOM-2 TABLETS Current status: Dormant Brand name: UNISOM-2 TABLETS Company: PALADIN LABS INC Dosage form: Tablet Route of administration: Oral Active ingredients and strength: DOXYLAMINE SUCCINATE 25 mg. All company submissions, Health Canada correspondence, reviewer notes, labels, quality, safety and efficacy data, and other related information as it pertains to the product listed above.Organization: Health Canada
November 2021
Req # A-2020-001436
The manual the Access to Information and Privacy (ATIP) Office consult when processing a request. A recent set of training materials, such as a presentation, that the ATIP office gives to employees about Public Health Agency of Canada (PHAC) about their responsibilities under the Access to Information Act and Privacy Act.Organization: Health Canada
November 2021
Req # A-2021-000131
All records in possession of the Ministry. Copies of the interprovincial billing rates for all provinces and for all outpatient and inpatient services including daily ward and Intensive Care Unit (ICU) rates for April onward. The interprovincial billing rates effective: April 1st, 2020 and April 1st, 2021.Organization: Health Canada
November 2021
Req # A-2021-000242
The number of analysts/public servants processing access to information files, broken down by year and by category at Health Canada for the following years: 2015, 2016, 2017, 2018, 2019, 2020 and 2021 to date, May 14, 2021.Organization: Health Canada
November 2021
Req # A-2021-000410
The number of Health Canada device licences applied for by LUMITHERA, INC., Corporate Headquarters, 19578 10th Ave NE STE 200, Poulsbo, Washington, 98370, between 2016 and July 6, 2021.Organization: Health Canada
November 2021
Req # A-2021-000465
Finished product specifications. Brand name - Inofolic Softgel Capsule Natural Product Number (NPN) - 80083082.Organization: Health Canada
November 2021